Literature DB >> 15196999

Induction of the differentiation and apoptosis of tumor cells in vivo with efficiency and selectivity.

Sinan Tabs1, Oktay Avci.   

Abstract

Hedgehog/smoothened signaling is active in a variety of tumors and is also involved in the maintenance of normal stem cells in vivo. We evaluated the possibility of preferential affection of tumor versus normal cells following inhibition of this signaling. We applied a cream preparation of cyclopamine (an inhibitor of the hedgehog/smoothened signaling) onto skin tumors in patients who were scheduled for the excision of these tumors (four basal cell carcinomas and a trichoepithelioma in four unrelated patients). All of the cyclopamine-treated tumors regressed rapidly. Histological and immunohistochemical analyses showed inhibition of the proliferation and highly efficient induction of the differentiation and apoptosis of tumor cells by a non-genotoxic mechanism. No adverse effects were noted and normal skin tissue and putative stem cells that were exposed to cyclopamine together with tumors were well preserved under the conditions we describe. Our findings show selective and highly efficient induction of the differentiation and apoptosis of tumor cells in vivo by transient inhibition of the hedgehog/ smoothened signaling and provide a rational cancer therapy. Copyright John Libbey Eurotext 2003.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196999

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  25 in total

Review 1.  Cancer stem cells: a new framework for the design of tumor therapies.

Authors:  Boyan K Garvalov; Till Acker
Journal:  J Mol Med (Berl)       Date:  2010-10-02       Impact factor: 4.599

2.  Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth.

Authors:  Jarrett R Remsberg; Hong Lou; Sergey G Tarasov; Michael Dean; Nadya I Tarasova
Journal:  J Med Chem       Date:  2007-08-08       Impact factor: 7.446

Review 3.  Basal cell carcinoma-treatments for the commonest skin cancer.

Authors:  Carola Berking; Axel Hauschild; Oliver Kölbl; Gerson Mast; Ralf Gutzmer
Journal:  Dtsch Arztebl Int       Date:  2014-05-30       Impact factor: 5.594

Review 4.  Development of anticancer agents targeting the Hedgehog signaling.

Authors:  Xiangqian Zhang; Ye Tian; Yanling Yang; Jijun Hao
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

Review 5.  Hedgehog signalling in breast cancer.

Authors:  Maria Kasper; Viljar Jaks; Marie Fiaschi; Rune Toftgård
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

Review 6.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

7.  Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo).

Authors:  Xiaomei Zhang; Nikesha Harrington; Ricardo C Moraes; Meng-Fen Wu; Susan G Hilsenbeck; Michael T Lewis
Journal:  Breast Cancer Res Treat       Date:  2008-06-19       Impact factor: 4.872

Review 8.  Sonic hedgehog signaling in Basal cell nevus syndrome.

Authors:  Mohammad Athar; Changzhao Li; Arianna L Kim; Vladimir S Spiegelman; David R Bickers
Journal:  Cancer Res       Date:  2014-08-29       Impact factor: 12.701

Review 9.  [Hereditary tumor syndromes. Cutaneous manifestations and molecular pathogenesis of Gorlin and Cowden syndromes].

Authors:  J Reifenberger
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

10.  Smoothened as a new therapeutic target for human osteosarcoma.

Authors:  Masataka Hirotsu; Takao Setoguchi; Hiromi Sasaki; Yukihiro Matsunoshita; Hui Gao; Hiroko Nagao; Osamu Kunigou; Setsuro Komiya
Journal:  Mol Cancer       Date:  2010-01-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.